Marie Thérèse Closon-Dejardin

Author

Also Known As

M T Closon-Dejardin, M.-T. Closon-Dejardin, Marie T. Closon-Dejardin, Marie Thérèse Closon-Dejardin

Publications

305

Citations

H-Index

Concepts

All Affiliations

Marie Thérèse Closon-Dejardin is an author at Institut Jules Bordet specializing in cancer therapeutics, radiation oncology, and breast cancer.

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	107
2	Pathology	1	1	107
3	Cancer Therapeutics	1	1	107
4	Breast Cancer	1	1	107
5	Oncology	1	1	107

Marie Thérèse Closon-Dejardin

Publications

299

Citations

H-Index

Page 1

	Year	Citations
Phase III Trial Comparing Two Dose Levels of Epirubicin Combined With Cyclophosphamide With Cyclophosphamide, Methotrexate, and Fluorouracil in Node-Positive Breast Cancer Martine Piccart, Angelo Di Leo, M. Beauduin, Journal of Clinical Oncology	2001	163
HER-2 and topo-isomerase IIα as predictive markers in a population of node-positive breast cancer patients randomly treated with adjuvant CMF or epirubicin plus cyclophosphamide Angelo Di Leo, Denis Larsimont, David Gancberg, Annals of Oncology Breast OncologyPredictive MarkersTopo-isomerase IiαMedicinePathology	2001	107
Long-Term Benefit of High-Dose Epirubicin in Adjuvant Chemotherapy for Node-Positive Breast Cancer: 15-Year Efficacy Results of the Belgian Multicentre Study Evandro de Azambuja, Marianne Paesmans, M. Beauduin, Journal of Clinical Oncology	2008	29

Page 1